Caribou Biosciences, Inc.
CRBU · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $217,373 | $117,216 | $84,626 | $143,606 |
| - Cash | $11,144 | $25,201 | $29,417 | $16,293 |
| + Debt | $25,464 | $25,851 | $26,224 | $26,487 |
| Enterprise Value | $231,693 | $117,866 | $81,433 | $153,800 |
| Revenue | $2,198 | $2,667 | $2,353 | $2,077 |
| % Growth | -17.6% | 13.3% | 13.3% | – |
| Gross Profit | $1,567 | $2,667 | $2,353 | -$27,787 |
| % Margin | 71.3% | 100% | 100% | -1,337.8% |
| EBITDA | -$26,917 | -$34,261 | -$41,748 | -$37,091 |
| % Margin | -1,224.6% | -1,284.6% | -1,774.2% | -1,785.8% |
| Net Income | -$27,548 | -$54,098 | -$39,991 | -$35,490 |
| % Margin | -1,253.3% | -2,028.4% | -1,699.6% | -1,708.7% |
| EPS Diluted | -0.3 | -0.58 | -0.43 | -0.39 |
| % Growth | 48.3% | -34.9% | -10.3% | – |
| Operating Cash Flow | -$25,185 | -$28,258 | -$36,725 | -$35,470 |
| Capital Expenditures | -$115 | -$418 | -$1,042 | -$518 |
| Free Cash Flow | -$25,300 | -$28,676 | -$37,767 | -$35,988 |